AbbVie’s migraine drug meets main goal in head-to-head study with topiramate
(Reuters) -AbbVie said on Wednesday its migraine drug met the main goal and was superior to a widely used generic…
(Reuters) -AbbVie said on Wednesday its migraine drug met the main goal and was superior to a widely used generic…
By Ahmed Aboulenein WASHINGTON (Reuters) -U.S. Senate Democrats demanded on Wednesday Health Secretary Robert F. Kennedy Jr. make public the…
By Stephen Nellis SAN FRANCISCO (Reuters) -SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia,…
By Maria Tsvetkova CAMBRIDGE, Massachusetts (Reuters) -When 35-year-old Oscar Escobar completed his term as the youngest elected mayor in his…
Early Access Ends Tonight – 5 Stocks to Watch Now In Today’s News Trading Options in 2025 [sponsor] [adv] US retail…
By Howard Schneider WASHINGTON (Reuters) -Federal Reserve policymakers will begin a two-day meeting on Tuesday with escalating tensions in the…
By Ethan Wang and Liz Lee BEIJING (Reuters) -China is “deeply worried” about Israel’s military operation against Iran that has…
By Kanishka Singh WASHINGTON (Reuters) -U.S. President Donald Trump said he wanted a “real end” to the nuclear problem with…
By Stephen Nellis SAN FRANCISCO (Reuters) -Oracle said on Tuesday that its cloud computing division is working with Elon Musk’s…
WASHINGTON (Reuters) -U.S. retail sales dropped more than expected in May, weighed down by a decline in motor vehicle purchases…